We are delighted to announce that Prof. Fred S. Apple, a key opinion leader in cardiac biomarker research, joined the HyTest Board of Directors in April 2016.

Fred S. Apple, Ph.D. is Medical Director of Clinical Laboratories at Hennepin County Medical Center in Minneapolis, MN, and Professor of Laboratory Medicine and Pathology at the University of Minnesota School of Medicine, Minnesota, USA.

He is one of the key opinion leaders in the field of cardiovascular disease biomarker research. Furthermore, he has either authored or co-authored over 150 scientific papers and served as an Associate Editor of Clinical Chemistry for over 15 years.

Dr. Apple has also been a member of the ‘National Academy of Clinical Biochemistry’ Laboratory Practice committee, the ‘Joint ESC-ACCF-AHA-WHF Global Task Force’ and the ‘Universal Definition of Myocardial Infarction’ biomarker subcommittee which established clinical and laboratory practice guidelines for the use of biomarkers for acute coronary syndromes and heart failure. Finally, he is a member of the IFCC "Task Force on Clinical Application of Cardiac Biomarkers ".

Dr. Apple and his group have been collaborating with HyTest for over a decade and have published five research papers. This long term relationship, which is based on mutual respect, led to the proposal that Dr. Apple join the Board. “Dr. Apple is a renowned and highly respected thought leader in his field. His broad experience in cardiac diagnostics will bring important insight to our company and assist us in our aim to develop the best reagents for detecting cardiac biomarkers. He will also be able to help us better understand the needs of practicing clinicians in cardiac disease diagnostics. We are greatly honored that he accepted our invitation to join our Board of Directors” stated Dr. Maria Severina, CEO of HyTest.